You are here

Tony Futerman

MRI brain scans of mice with Gaucher disease Type III. The scan of a mouse that received the new treatment (left) shows a significant reduction in tissue inflammation (blue) compared to an untreated mouse (right)
13.10.2024

An innovative treatment for Gaucher disease has produced promising results in mice, giving hope to patients after decades of...

Yeda News
01.10.2020

Gene Therapy Firm Enters Collaboration Agreement with Weizmann Lab

signs of inflammation in the brain
14.11.2016

New research explains the link between Parkinson’s disease and a rare inherited disorder

g-incpm staff
21.08.2016

Meet the unique team of experts at the Nancy and Stephen Grand Israel National Center for Personalized Medicine

(l-r) Drs. Yael Elbaz-Alon and Maya Schuldiner
03.08.2014

A cellular organelle reveals a surprising backup resource for obtaining important building materials

Elevation of RIP3 in nuclei of neurons from neuronopathic Gaucher (red; arrows) disease mice
20.01.2014

Weizmann Institute findings may point the way to a treatment for a devastating childhood disease

 

Prof. Anthony (Tony) Futerman
02.09.2010

The accumulation of too many lipids in a cell leads to a number of hereditary diseases that in particular afflict Ashkenazic Jews: Tay-Sachs,...

Deciphering Gaucher's Disease
01.10.2003

New finding may lead to more effective – and affordable – treatments

Glucocerebrosidase
02.06.2003
The discovery may help design effective therapies for the genetic disease that mainly affects Ashkenazi Jews...
Six Prizes to Weizmann Institute Scientists
10.06.1996

REHOVOT, Israel -- June 10, 1996 -- Six outstanding Weizmann Institute scientists...